Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy.

European journal of cancer (Oxford, England : 1990) - 1 Jun 2020

Torricelli Federica, Saxena Alka, Nuamah Rosamond, Neat Michael, Harling Leanne, Ng Wen, Spicer James, Ciarrocchi Alessia, Bille Andrea

Abstract excerpt

BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive tumour with poor prognosis. The aim of this study was to identify genetic mutations associated with poor or extended survival in patients who received palliative chemotherapy. METHODS: A total of 720 patients diagnosed with MPM between 2005 and 2015 were identified. Overall survival (OS) was longer than 30 months from diagnosis for 27 patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Electron Transport Complex III
Share to Guanine Nucleotide Exchange Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mesothelioma

Share to Mesothelioma, Malignant

Share to Palliative Care

Share to Pleural Neoplasms

Share to Proteoglycans

Share to Survival Rate

Source

Identifiers

PMID: 32339978
DOI: 10.1016/j.ejca.2020.03.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy.PMID 32339978Read ↗

Genomics and Functional Genomics of Malignant Pleural MesotheliomaSemantic proximity Read ↗

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesotheliomaSemantic proximity Read ↗

Progress and challenges in Mesothelioma: From bench to bedside.Semantic proximity Read ↗

Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.Semantic proximity Read ↗

Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.Semantic proximity Read ↗

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.Semantic proximity Read ↗

Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma.Semantic proximity Read ↗

Transcriptomics based prediction of survival and response to therapy in malignant mesotheliomaSemantic proximity Read ↗

Genomic Landscape of Malignant Mesotheliomas.Semantic proximity Read ↗

Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.Semantic proximity Read ↗

Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas.Semantic proximity Read ↗

Genome-wide silencing screen in mesothelioma cells reveals that loss of function of BAP1 induces chemoresistance to ribonucleotide reductase inhibition: implication for therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.